Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer

被引:78
|
作者
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Kawauchi, Shigeto
Matsumoto, Hiroaki
Nagao, Kazuhiro
Ohmi, Chietaka
Sakano, Shigeru
Furuya, Tomoko
Oga, Atsunori
Naito, Katsusuke
Sasaki, Kohsuke [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Pathol, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Urol, Ube, Yamaguchi 7558505, Japan
关键词
bladder cancer; centrosome amplification; chromosomal instability; polo-like kinase 1;
D O I
10.1159/000094416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polo-like kinase 1 (PLK1) participates in bipolar spindle formation and entry into mitosis. Chromosomal instability (CIN) is caused by abnormalities in spindle formation and chromosome segregation. In this study, we investigated the relationship of PLK1 overexpression to CIN, and compared the PLK1 status with clinicopathological parameters in 101 human urothelial carcinomas of the urinary bladder. Expression of PLK1 and the number of centrosomes were assessed by immunohistochemistry. Numerical aberrations of chromosomes 7, 9 and 17 spots that allowed estimation of CIN were evaluated by fluorescence in situ hybridization, and DNA ploidy was assessed by laser scanning cytometry. Cancers with a large intercellular variation in centromere copy number were defined as CIN cancers. Tumors with PLK1 overexpression were associated more frequently with CIN (p < 0.0001), DNA aneuploicly (p = 0.0007) and centrosome amplification (p = 0.0013) than those without. Overexpression of PLKI was significantly related to higher pathological grade (p = 0.0024), multiple tumors (p = 0.0241) and positive urine cytology (p = 0.0192). These data suggest that a high level expression of PLK1 confers tumor progression advantages to urothelial cancer cells, although other factors are also involved. Copyright (c) 2006 S. Karger AG, Basel
引用
收藏
页码:231 / 237
页数:7
相关论文
共 50 条
  • [1] Polo-like kinase 1 (PLK1) signaling in cancer and beyond
    Iliaki, Styliani
    Beyaert, Rudi
    Afonina, Inna S.
    BIOCHEMICAL PHARMACOLOGY, 2021, 193
  • [2] Overexpression of Polo-like kinase1 (PLK1) in chondrosarcoma and its implications for cancer progression
    Li, Kelu
    Ma, Hongmei
    Zheng, Xiuyan
    Hu, Yali
    Wang, Yue
    Zhang, Kunpeng
    Chen, Jiahan
    Qi, Yan
    Jiang, Jinfang
    Pang, Lijuan
    Tao, Lin
    Gu, Wenyi
    Li, Feng
    Zou, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (03): : 1707 - 1711
  • [3] Molecular Interactions of Polo-like Kinase 1 (PLK1) in Colorectal Cancer
    Ng, W. T. W.
    Shin, J.
    Yang, T.
    Roberts, T.
    Wang, B.
    Begg, J.
    Lee, C. S.
    JOURNAL OF PATHOLOGY, 2016, 238 : S6 - S6
  • [4] Polo-like kinase 1 (Plk1) overexpression enhances ionizing radiation-induced cancer formation in mice
    Li, Zhiguo
    Liu, Jinghui
    Li, Jie
    Kong, Yifan
    Sandusky, George
    Rao, Xi
    Liu, Yunlong
    Wan, Jun
    Liu, Xiaoqi
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (42) : 17461 - 17472
  • [5] Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
    Takahashi, T
    Sano, B
    Nagata, T
    Kato, H
    Sugiyama, Y
    Kunieda, K
    Kimura, M
    Okano, Y
    Saji, S
    CANCER SCIENCE, 2003, 94 (02) : 148 - 152
  • [6] Polo-like kinase 1 (PLK1) regulates IFN induction by MAVS
    Vitour, Damien
    Dabo, Stephanie
    Pour, Malek Ahmadi
    Vilasco, Myriam
    Vidalain, Pierre-Olivier
    Jacob, Yves
    Mezel-Lemoine, Mariana
    Paz, Suzanne
    Arguello, Meztli
    Lin, Rongtuan
    Tangy, Frederic
    Hiscott, John
    Meurs, Eliane F.
    CYTOKINE, 2009, 48 (1-2) : 126 - 126
  • [7] Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
    Song, Bing
    Liu, X. Shawn
    Liu, Xiaoqi
    CELL DIVISION, 2012, 7
  • [8] Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
    Jani, Krupa S.
    Dalafave, D. S.
    BIOINFORMATICS AND BIOLOGY INSIGHTS, 2012, 6 : 23 - 31
  • [9] Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
    Bing Song
    X Shawn Liu
    Xiaoqi Liu
    Cell Division, 7
  • [10] Regulating a key mitotic regulator, polo-like kinase 1 (PLK1)
    Colicino, Erica G.
    Hehnly, Heidi
    CYTOSKELETON, 2018, 75 (11) : 481 - 494